Category: Gastroenterology and Endoscopy

What happened when Anthem cut GI anesthesia reimbursements?

Anthem Blue Cross Blue Shield recently reversed its decision on a controversial anesthesia reimbursement policy that could have deeply impacted gastroenterology services following intense pushback from providers and the general public. 

What happened when Anthem cut GI anesthesia reimbursements?

Anthem Blue Cross Blue Shield recently reversed its decision on a controversial anesthesia reimbursement policy that could have deeply impacted gastroenterology services following intense pushback from providers and the general public. 

5 moves that disrupted GI in 2024

Here are five major moves that disrupted gastroenterology in 2024:

US Digestive Health adds 19 providers

Exton, Pa.-based US Digestive Health has added 19 advanced practice providers to its network of specialists. 

US Digestive Health adds 19 providers

Exton, Pa.-based US Digestive Health has added 19 advanced practice providers to its network of specialists. 

Gastro Concepts earns FDA clearance for colonoscopy device

Gastro Concepts has secured FDA clearance for Air Assist, a device designed to prevent air and carbon dioxide from escaping during colonoscopy.

Colonoscopies in 2024: 11 things to know

Here are 11 studies, developments and legislative moves that changed the colonoscopy landscape in 2024:

Medtronic launches 1st-ever patient procedure ingestion using PillCam

Medtronic has partnered with the University of Miami Health System to perform the first-ever patient procedure ingestion using the PillCam Genius SB capsule endoscopy kit. 

$3M grant awarded to examine Ozempic effect on Crohn's disease

The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease. 

$3M grant awarded to examine Ozempic effect on Crohn's disease

The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease.